AnalystsUy EarUy Ear's Stock Forecasts
AnalystsUy Ear
Analyst Ranking
Bottom 7%
#4078 out of 4337 analysts
Average Return
-13.97%
Win Rate
35%7 out of 20
Risk vs Reward
Poor
Good
Uy Ear's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +89.75% | $8.10 | $15.37 | 2023-03-17 - 2023-09-25 | Strong Buy |
Avrobio IncAVRO | +56.92% | $0.98 | $1.53 | 2023-03-24 - 2023-09-25 | Strong Buy |
Alkermes PLCALKS | +18.78% | $24.50 | $29.10 | 2022-11-22 - 2023-09-25 | Strong Buy |
Evolus IncEOLS | +2.74% | $8.75 | $8.99 | 2023-06-07 - 2023-09-25 | Strong Buy |
Alkermes PLCALKS | +2.68% | $28.34 | $29.10 | 2023-04-27 - 2023-09-25 | Strong Buy |
Uy Ear Analyst Color
Get additional color on Uy Ear's coverage of popular stocks
Uy Ear's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 5 | Strong Buy | $57.00 | +886.16% | Reiterates | 18 hours ago |
Neurocrine Biosciences IncNBIX | 7 | Hold | $113.00 | -0.60% | Reiterates | 13 days ago |
Selecta Biosciences IncSELB | 2 | Strong Buy | $3.00 | +177.78% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 5 | Hold | $20.00 | -14.13% | Reiterates | 3 months ago |
Evolus IncEOLS | 2 | Strong Buy | $20.00 | +122.47% | Maintains | 4 months ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $40.00 | -75.04% | Maintains | 4 months ago |
Alkermes PLCALKS | 3 | Strong Buy | $36.00 | +23.71% | Maintains | 5 months ago |
Sarepta Therapeutics IncSRPT | 2 | Strong Buy | $160.00 | +39.45% | Reiterates | 5 months ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Hold | $2.00 | +81.82% | Reiterates | 6 months ago |
Avrobio IncAVRO | 2 | Strong Buy | $5.00 | +226.80% | Maintains | 6 months ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $10.00 | -34.94% | Reiterates | 6 months ago |
Ocugen IncOCGN | 2 | Strong Buy | $3.00 | +650.00% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.